Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05558813

Natural History of Duchenne Muscular Dystrophy Cardiomyopathy (DMD-CMP)

Prospective Cardiac Magnetic Resonance Imaging Study in Duchenne Muscular Dystrophy (DMD-CMP)

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
Male
Age
6 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to describe the progression of tissular and functional myocardial abnormalities in patients with Duchenne muscular dystrophy using cardiac magnetic resonance imaging and blood biomarkers assays.

Detailed description

This study is to describe the progression of tissular (late gadolinium enhancement, T1, T2, ECV assessments) and functional (segmental and global contractility, strain) myocardial abnormalities in patients with Duchenne muscular dystrophy using cardiac magnetic resonance imaging and blood biomarkers assays (troponin I, NTproBNP). Comparison between baseline and 2-years assessments will be conducted.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCardiac MRItwo cardiac MRIs with Gadolinum injection at 2-year intervals
BIOLOGICALBlood assaysblood samples for the determination of blood biomarkers of heart failure (BNP, NTproBNP) and for the constitution of a biological collection

Timeline

Start date
2024-11-01
Primary completion
2029-02-01
Completion
2029-04-01
First posted
2022-09-28
Last updated
2025-11-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05558813. Inclusion in this directory is not an endorsement.

Natural History of Duchenne Muscular Dystrophy Cardiomyopathy (DMD-CMP) (NCT05558813) · Clinical Trials Directory